Deal Watch: WuXi/Gloria License PD-1 Inhibitor To Arcus For Up To $816m

 
• By Mandy Jackson and Sten Stovall

WuXi Biologics and Harbin Gloria will get $18.5m up front for the Phase I asset GLS-010. Also, Cerecor divests depression drug to Janssen for up to $45m and Perrigo sells its API division for $110m in cash.

DealWatch_1200x675

More from Deals

More from Business